Skip to main content

Table 3 The comparison of the zero mark-up policy in secondary hospitals

From: A cross-sectional analysis of prescription and stakeholder surveys following essential medicine reform in Guangdong Province, China

Zero mark-up

EMs/Rx number (%)

EM number

Total drug number

EMs/Rx cost (%)

EM cost (RMB)

Total Rx cost (RMB)

Hypertension

Adopted

100

2

2

100

30.2

65.5

(299)

(60–100)

(1–3)

(2–3)

(39–100)

(14.0-83.3)

(17.6-140.3)

Not adopted

75**

2**

3**

64**

51.3**

102.1**

(759)

(50–100)

(1–3)

(2–5)

(26–100)

(20.0-97.6)

(54.1-200.8)

Diabetes

Adopted

67

2

3

56

24.5

100.5

(304)

(50–100)

(1–3)

(2–3)

(13–100)

(9.6-105.3)

(39.9-189.3)

Not adopted

100**

2

3

99**

85.4**

136.0**

(860)

(50–100)

(1–3)

(1–4)

(52–100)

(38.7-180.9)

(69.5-261.1)

Gout

Adopted

75

3

3

66

11.6

30.5

(232)

(50–100)

(1–4)

(3–5)

(14–100)

(4.3-25.3)

(13.8-82.1)

Not adopted

75

2**

3**

84

21.0**

35.9

(724)

(50–100)

(1–4)

(2–4)

(21–100)

(5.2-31.5)

(21.4-62.1)

Bacterial infections

Adopted

60

2

3

55

32.6

76.0

(297)

(30–100)

(1–3)

(2–4)

(8–100)

(3.6-71.5)

(42.0-117.9)

Not adopted

60

2**

3**

43

31.0

88.6**

(899)

(40–80)

(1–3)

(3–5)

(14–88)

(12.2-65.3)

(53.2-139.4)

  1. Rx = prescription; EMs = essential medicines.
  2. On June 1, 2012, at the beginning of the survey, the conversion rate was RMB 6.33 to USD 1.00. Data are shown as medians (25th–75th interquartile range). **p < 0.01 compared with the zero mark-up group.